Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04083976
Title A Study of Erdafitinib in Participants With Advanced Solid Tumors and Fibroblast Growth Factor Receptor (FGFR) Gene Alterations
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Janssen Research & Development, LLC
Indications

Advanced Solid Tumor

Therapies

Erdafitinib

Age Groups: adult | senior | child
Covered Countries USA